New hope for kids with bowel disease: 8-Week treatment trial
NCT ID NCT04314375
Summary
This study is testing whether budesonide extended-release tablets can help children aged 5-17 with mild to moderate ulcerative colitis achieve remission. Participants will take either the medication or a placebo for 8 weeks while continuing their standard background treatments. The main goal is to see if more children taking the medication achieve clinical remission compared to those taking the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bausch Health Site 003
RECRUITINGIndianapolis, Indiana, 46202, United States
-
Bausch Health Site 006
RECRUITINGThe Bronx, New York, 10467, United States
-
Bausch Health Site 008
RECRUITINGGarden Grove, California, 92845, United States
-
Bausch Health Site 010
RECRUITINGGreenville, North Carolina, 27834, United States
Conditions
Explore the condition pages connected to this study.